Literature DB >> 11581056

An in vitro resistance study of levofloxacin, ciprofloxacin, and ofloxacin using keratitis isolates of Staphylococcus aureus and Pseudomonas aeruginosa.

R P Kowalski1, A N Pandya, L M Karenchak, E G Romanowski, R C Husted, D C Ritterband, M K Shah, Y J Gordon.   

Abstract

PURPOSE: We compared levofloxacin with ciprofloxacin and ofloxacin using the in vitro susceptibilities of Staphylococcus aureus (SA) and Pseudomonas aeruginosa (PA) keratitis isolates.
DESIGN: Retrospective, clinical laboratory study of antibiotic susceptibility among keratitis isolates. PARTICIPANTS: Keratitis isolates from 200 patients with either SA or PA keratitis.
METHODS: Minimum inhibitory concentrations (MICs) were determined for levofloxacin, ofloxacin, and ciprofloxacin for 93 SA keratitis isolates (68 fluoroquinolone-resistant and 25 susceptible, as determined by disk diffusion) and 107 PA keratitis isolates (13 fluoroquinolone-resistant and 94 susceptible). National Committee for Clinical Laboratory Standards susceptibilities were determined and analyzed statistically. Time kill studies were determined for fluoroquinolone-susceptible and -resistant isolates to all antibiotics at 8 microg/ml. The killing rates were determined by regression, and the colony count decreases were analyzed. MAIN OUTCOME MEASURES: The susceptibilities and potencies of levofloxacin, ciprofloxacin, and ofloxacin to SA and PA were determined from the MICs. Time kill studies determined the killing rates and decreases in colony counts.
RESULTS: The fluoroquinolone-resistant SA susceptibilities to levofloxacin, ofloxacin, and ciprofloxacin were only 22%, 10%, and 3%, respectively. The fluoroquinolone-susceptible SA were 100% susceptible to all antibiotics, with levofloxacin demonstrating the best potency. The fluoroquinolone-resistant PA were resistant to all antibiotics. The fluoroquinolone-susceptible PA isolates were highly susceptible to levofloxacin, ofloxacin, and ciprofloxacin, with ciprofloxacin demonstrating the highest potency. For fluoroquinolone-susceptible SA and PA, the time kill studies determined that the killing rates and decreases in colony counts were equivalent for all three antibiotics tested. The time kill studies demonstrated no colony count decreases for the fluoroquinolone-resistant SA and PA.
CONCLUSIONS: Taken together, our susceptibility and time kill data failed to demonstrate convincing differences in the susceptibility of SA and PA keratitis isolates to levofloxacin, ciprofloxacin, and ofloxacin. In general, bacterial isolates that were resistant to ciprofloxacin and ofloxacin were also resistant to levofloxacin.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11581056     DOI: 10.1016/s0161-6420(01)00724-2

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  12 in total

1.  Resistance to fluoroquinolones and methicillin in ophthalmic isolates of Staphylococcus pseudintermedius from companion animals.

Authors:  Min-Hee Kang; Min-Joo Chae; Jang-Won Yoon; So-Young Lee; Jong-Hyun Yoo; Hee-Myung Park
Journal:  Can Vet J       Date:  2014-07       Impact factor: 1.008

2.  [Photodynamic therapy for infectious keratitis].

Authors:  N Szentmáry; S Goebels; M Bischoff; B Seitz
Journal:  Ophthalmologe       Date:  2012-02       Impact factor: 1.059

3.  Effect of Ciprofloxacin, Levofloxacin, and Ofloxacin on Pseudomonas aeruginosa: A case control study with time kill curve analysis.

Authors:  Tiar Sondang Uli Sihotang; Agung Dwi Wahyu Widodo; Pepy Dwi Endraswari
Journal:  Ann Med Surg (Lond)       Date:  2022-09-16

4.  Impact of photodynamic inactivation (PDI) using the photosensitizer chlorin e6 on viability, apoptosis, and proliferation of human corneal endothelial cells.

Authors:  Jiong Wang; Tanja Stachon; Timo Eppig; Achim Langenbucher; Berthold Seitz; Nóra Szentmáry
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-12-22       Impact factor: 3.117

5.  Xylose-Inducible Promoter Tools for Pseudomonas Species and Their Use in Implicating a Role for the Type II Secretion System Protein XcpQ in the Inhibition of Corneal Epithelial Wound Closure.

Authors:  Jake D Callaghan; Nicholas A Stella; Kara M Lehner; Benjamin R Treat; Kimberly M Brothers; Anthony J St Leger; Robert M Q Shanks
Journal:  Appl Environ Microbiol       Date:  2020-07-02       Impact factor: 4.792

6.  In vitro comparison of combination and monotherapy for the empiric and optimal coverage of bacterial keratitis based on incidence of infection.

Authors:  Regis P Kowalski; Tyler A Kowalski; Robert M Q Shanks; Eric G Romanowski; Lisa M Karenchak; Francis S Mah
Journal:  Cornea       Date:  2013-06       Impact factor: 2.651

7.  An Eye to a Kill: Using Predatory Bacteria to Control Gram-Negative Pathogens Associated with Ocular Infections.

Authors:  Robert M Q Shanks; Viral R Davra; Eric G Romanowski; Kimberly M Brothers; Nicholas A Stella; Dipti Godboley; Daniel E Kadouri
Journal:  PLoS One       Date:  2013-06-18       Impact factor: 3.240

8.  Identification and antimicrobial susceptibility of microorganisms isolated from severe corneal ulcers of dogs in Thailand.

Authors:  Daneeya Ekapopphan; Athicha Srisutthakarn; Walasinee Moonarmart; Ruangrat Buddhirongawatr; Norasuthi Bangphoomi
Journal:  J Vet Med Sci       Date:  2018-06-20       Impact factor: 1.267

Review 9.  Emergence of antibiotic resistance Pseudomonas aeruginosa in intensive care unit; a critical review.

Authors:  Preeti Pachori; Ragini Gothalwal; Puneet Gandhi
Journal:  Genes Dis       Date:  2019-04-17

10.  Efficacy of Gatifloxacin in Acute Bacterial Corneal ulcer.

Authors:  Sameen Afzal Junejo; Arshad Ali Lodhi; Munawar Ahmed; Mahesh Kumar; Mustafa Kamal
Journal:  Pak J Med Sci       Date:  2013-11       Impact factor: 1.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.